Compugen Net Income vs. Revenue

CGEN Stock  USD 1.41  0.04  2.76%   
Considering Compugen's profitability and operating efficiency indicators, Compugen may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Compugen's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2000-03-31
Previous Quarter
-2.1 M
Current Value
1.3 M
Quarterly Volatility
3.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, Compugen's Days Sales Outstanding is very stable compared to the past year. As of the 24th of November 2024, Days Of Sales Outstanding is likely to grow to 702.36, while Price To Sales Ratio is likely to drop 4.98. At this time, Compugen's Net Income Per E B T is very stable compared to the past year.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.880.9401
Notably Down
Slightly volatile
For Compugen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Compugen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Compugen utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Compugen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Compugen over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Compugen. If investors know Compugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Compugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.03
Revenue Per Share
0.48
Quarterly Revenue Growth
3.461
Return On Assets
(0.03)
Return On Equity
(0.16)
The market value of Compugen is measured differently than its book value, which is the value of Compugen that is recorded on the company's balance sheet. Investors also form their own opinion of Compugen's value that differs from its market value or its book value, called intrinsic value, which is Compugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Compugen's market value can be influenced by many factors that don't directly affect Compugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compugen Revenue vs. Net Income Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Compugen's current stock value. Our valuation model uses many indicators to compare Compugen value to that of its competitors to determine the firm's financial worth.
Compugen is rated fourth in net income category among its peers. It also is rated fourth in revenue category among its peers . Compugen reported last year Net Loss of (18.75 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Compugen's earnings, one of the primary drivers of an investment's value.

Compugen Revenue vs. Net Income

Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Compugen

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(18.75 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Compugen

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
33.46 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Compugen Revenue vs Competition

Compugen is rated fourth in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 645.82 Million. Compugen holds roughly 33.46 Million in revenue claiming about 5% of equities under Health Care industry.

Compugen Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Compugen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Compugen will eventually generate negative long term returns. The profitability progress is the general direction of Compugen's change in net profit over the period of time. It can combine multiple indicators of Compugen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income2.3 K2.4 K
Operating Income-13 M-13.6 M
Income Before Tax-9.8 M-10.3 M
Total Other Income Expense Net3.2 M3.4 M
Net Loss-18.8 M-19.7 M
Income Tax ExpenseM9.4 M
Net Loss-18.8 M-19.7 M
Net Loss-30.3 M-31.8 M
Interest IncomeM3.1 M
Net Interest Income3.2 M3.4 M
Change To Netincome4.9 M2.9 M
Net Loss(0.21)(0.22)
Income Quality 1.91  2.01 
Net Income Per E B T 1.92  2.01 

Compugen Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Compugen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Compugen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Compugen's important profitability drivers and their relationship over time.

Use Compugen in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Compugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Compugen will appreciate offsetting losses from the drop in the long position's value.

Compugen Pair Trading

Compugen Pair Trading Analysis

The ability to find closely correlated positions to Compugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Compugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Compugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Compugen to buy it.
The correlation of Compugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Compugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Compugen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Compugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Compugen position

In addition to having Compugen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Trump Equities Thematic Idea Now

Trump Equities
Trump Equities Theme
Stocks that have significantly increased in valuation since Trump was elected president of the United States. The Trump Equities theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Trump Equities Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities.
To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
To fully project Compugen's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Compugen at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Compugen's income statement, its balance sheet, and the statement of cash flows.
Potential Compugen investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Compugen investors may work on each financial statement separately, they are all related. The changes in Compugen's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Compugen's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.